ArticleVaccines2022

Early Real-World Data to Assess Benefits and Risks of COVID-19 Vaccines: A Systematic Review of Methods.

Tatiane B Ribeiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.